Human ZMPSTE24 disease mutations: residual proteolytic activity correlates with disease severity
Authors:
Open Access
- 19 June 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 21 (18) , 4084-4093
Abstract
The zinc metalloprotease ZMPSTE24 plays a critical role in nuclear lamin biology by cleaving the prenylated and carboxylmethylated 15-amino acid tail from the C-terminus of prelamin A to yield mature lamin A. A defect in this proteolytic event, caused by a mutation in the lamin A gene (LMNA) that eliminates the ZMPSTE24 cleavage site, underlies the premature aging disease Hutchinson-Gilford Progeria Syndrome (HGPS). Likewise, mutations in the ZMPSTE24 gene that result in decreased enzyme function cause a spectrum of diseases that share certain features of premature aging. Twenty human ZMPSTE24 alleles have been identified that are associated with three disease categories of increasing severity: mandibuloacral dysplasia type B (MAD-B), severe progeria (atypical ‘HGPS’) and restrictive dermopathy (RD). To determine whether a correlation exists between decreasing ZMPSTE24 protease activity and increasing disease severity, we expressed mutant alleles of ZMPSTE24 in yeast and optimized in vivo yeast mating assays to directly compare the activity of alleles associated with each disease category. We also measured the activity of yeast crude membranes containing the ZMPSTE24 mutant proteins in vitro. We determined that, in general, the residual activity of ZMPSTE24 patient alleles correlates with disease severity. Complete loss-of-function alleles are associated with RD, whereas retention of partial, measureable activity results in MAD-B or severe progeria. Importantly, our assays can discriminate small differences in activity among the mutants, confirming that the methods presented here will be useful for characterizing any new ZMPSTE24 mutations that are discovered.Keywords
This publication has 60 references indexed in Scilit:
- Type B mandibuloacral dysplasia with congenital myopathy due to homozygous ZMPSTE24 missense mutationEuropean Journal of Human Genetics, 2011
- Early onset mandibuloacral dysplasia due to compound heterozygous mutations in ZMPSTE24American Journal of Medical Genetics Part A, 2010
- Analysis of Prelamin A Biogenesis Reveals the Nucleus to be a CaaX Processing CompartmentMolecular Biology of the Cell, 2008
- A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse modelProceedings of the National Academy of Sciences, 2008
- HIV-protease inhibitors block the enzymatic activity of purified Ste24pBiochemical and Biophysical Research Communications, 2008
- Phenotype and Course of Hutchinson–Gilford Progeria SyndromeNew England Journal of Medicine, 2008
- HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cellsProceedings of the National Academy of Sciences, 2007
- “Laminopathies”: A wide spectrum of human diseasesExperimental Cell Research, 2007
- A homozygousZMPSTE24null mutation in combination with a heterozygous mutation in theLMNAgene causes Hutchinson-Gilford progeria syndrome (HGPS): insights into the pathophysiology of HGPSHuman Mutation, 2006
- The nuclear lamina comes of ageNature Reviews Molecular Cell Biology, 2005